Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin

Clinical trial NCT00111982 · COMPLETED

Trial details

NCT number: NCT00111982
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2003-12-01
Primary completion: 2005-11-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.